Quantitative Evaluation of Aldo–keto Reductase Expression in Hepatocellular Carcinoma (HCC) Cell Lines
暂无分享,去创建一个
Lei Yang | Weiwei Dong | Siqi Liu | Ju Zhang | Xiaomin Lou | Shenyan Zhang | Siqi Liu | Weiwei Dong | Xiaomin Lou | Ju Zhang | Shenyan Zhang | Lei Yang
[1] B. Wermuth,et al. The aldo-keto reductase superfamily. cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. , 1989, The Journal of biological chemistry.
[2] A. Otto,et al. Identification of tumor-associated protein variants during rat hepatocarcinogenesis. Aldose reductase. , 1994, The Journal of biological chemistry.
[3] N. Taniguchi,et al. Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines: Implication in detoxification of cytotoxic aldehydes , 1995, International journal of cancer.
[4] M. Lewis,et al. Comparative anatomy of the aldo-keto reductase superfamily. , 1997, The Biochemical journal.
[5] Sheung Tat Fan,et al. Identification and Characterization of a Novel Human Aldose Reductase-like Gene* , 1998, The Journal of Biological Chemistry.
[6] G. FitzGerald,et al. Molecular Evolution of the Aldo-keto Reductase Gene Superfamily , 1998, Journal of Molecular Evolution.
[7] J. Groopman,et al. cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3. , 1999, Carcinogenesis.
[8] Michael E. Burczynski,et al. Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1–AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones , 2000 .
[9] N. Palackal,et al. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. , 2000, The Biochemical journal.
[10] Mark A. Knepper,et al. Aldose Reductase-Deficient Mice Develop Nephrogenic Diabetes Insipidus , 2000, Molecular and Cellular Biology.
[11] M. Young,et al. Functional genomic studies of aldo-keto reductases. , 2001, Chemico-biological interactions.
[12] J. Jez,et al. The aldo-keto reductase (AKR) superfamily: an update. , 2001, Chemico-biological interactions.
[13] Tzei-Yi Lin,et al. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer. , 2001, Cancer research.
[14] N. Palackal,et al. Activation of Polycyclic Aromatic Hydrocarbontrans-Dihydrodiol Proximate Carcinogens by Human Aldo-keto Reductase (AKR1C) Enzymes and Their Functional Overexpression in Human Lung Carcinoma (A549) Cells* , 2002, The Journal of Biological Chemistry.
[15] Laurent Vergnes,et al. A cluster of eight hydroxysteroid dehydrogenase genes belonging to the aldo-keto reductase supergene family on mouse chromosome 13 Published, JLR Papers in Press, December 1, 2002. DOI 10.1194/jlr.M200399-JLR200 , 2003, Journal of Lipid Research.
[16] Trevor M. Penning,et al. Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3α-hydroxysteroid dehydrogenase/type 5 17β-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate , 2004, Steroids.
[17] F. Stanczyk,et al. Selective Loss of AKR1C1 and AKR1C2 in Breast Cancer and Their Potential Effect on Progesterone Signaling , 2004, Cancer Research.
[18] Wendy J Mack,et al. Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study , 2005, Breast Cancer Research.
[19] T. Penning,et al. Structure–function of human 3α-hydroxysteroid dehydrogenases: genes and proteins , 2004, Molecular and Cellular Endocrinology.
[20] Liang-Shun Wang,et al. Inverse expression of dihydrodiol dehydrogenase and glutathione‐S‐transferase in patients with esophageal squamous cell carcinoma , 2004, International journal of cancer.
[21] T. Penning,et al. Structure-function of human 3 alpha-hydroxysteroid dehydrogenases: genes and proteins. , 2004, Molecular and cellular endocrinology.
[22] Trevor M Penning,et al. The roles of aldo-keto reductases in steroid hormone action. , 2004, Drug news & perspectives.
[23] Trevor M Penning,et al. AKR1B10: A New Diagnostic Marker of Non–Small Cell Lung Carcinoma in Smokers , 2005, Clinical Cancer Research.
[24] Hiroyuki Aburatani,et al. Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokers' Non–Small Cell Lung Carcinomas , 2005, Clinical Cancer Research.
[25] Donna M. Peehl,et al. Aldo-keto reductase (AKR) 1C3: Role in prostate disease and the development of specific inhibitors , 2006, Molecular and Cellular Endocrinology.
[26] Peter Boyle,et al. Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma , 2007, Human Genetics.
[27] Tea Lanišnik Rižner,et al. AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer , 2006, Molecular and Cellular Endocrinology.
[28] Nadarajah Vigneswaran,et al. Cigarette smoke condensate induces cytochromes P450 and aldo-keto reductases in oral cancer cells. , 2006, Toxicology letters.
[29] M. Srinivasulu,et al. Overexpression of aldose reductase in human cancer tissues. , 2006, Medical science monitor : international medical journal of experimental and clinical research.
[30] Hsueh-Kung Lin,et al. Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma. , 2006, Endocrine-related cancer.
[31] Ming-Chih Chou,et al. Overexpression of aldo-keto reductase 1C2 as a high-risk factor in bladder cancer. , 2007, Oncology reports.
[32] Yi Jin,et al. Aldo-keto reductases and bioactivation/detoxication. , 2007, Annual review of pharmacology and toxicology.
[33] Rong Wang,et al. Comparative analysis of the protein profiles from primary gastric tumors and their adjacent regions: MAWBP could be a new protein candidate involved in gastric cancer. , 2007, Journal of proteome research.
[34] Trevor M Penning,et al. Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms. , 2007, Archives of biochemistry and biophysics.
[35] Debra Silverman,et al. Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes. , 2008, Carcinogenesis.
[36] Trevor M Penning,et al. Comparisons of (+/-)-benzo[a]pyrene-trans-7,8-dihydrodiol activation by human cytochrome P450 and aldo-keto reductase enzymes: effect of redox state and expression levels. , 2008, Chemical research in toxicology.
[37] Hiroyuki Aburatani,et al. AKR1B10 in usual interstitial pneumonia: expression in squamous metaplasia in association with smoking and lung cancer. , 2008, Pathology, research and practice.
[38] Kun-Tu Yeh,et al. Overexpression of Dihydrodiol Dehydrogenase as a Prognostic Marker in Resected Gastric Cancer Patients , 2009, Digestive Diseases and Sciences.
[39] J Mark Petrash,et al. Disruption of aldo-keto reductase genes leads to elevated markers of oxidative stress and inositol auxotrophy in Saccharomyces cerevisiae. , 2008, Biochimica et biophysica acta.
[40] Wei Tong,et al. A new approach to monitor expression of aldo–keto reductase proteins in mouse tissues , 2009, Proteomics.
[41] Trevor M Penning,et al. Steroid Hormone Transforming Aldo‐Keto Reductases and Cancer , 2009, Annals of the New York Academy of Sciences.
[42] I-Ping Chiang,et al. Overexpression of aldo‐keto reductase 1C2 is associated with disease progression in patients with prostatic cancer , 2010, Histopathology.
[43] Fiona Campbell,et al. Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy , 2011, Molecular Cancer.
[44] Kota V Ramana,et al. Aldose reductase inhibition: emerging drug target for the treatment of cardiovascular complications. , 2010, Recent patents on cardiovascular drug discovery.
[45] Hyun-Ho Lim,et al. High-Efficiency Screening of Monoclonal Antibodies for Membrane Protein Crystallography , 2011, PloS one.
[46] E-S Lee,et al. AKR1B10 is Associated with Smoking and Smoking-Related Non-Small-Cell Lung Cancer , 2011, The Journal of international medical research.
[47] György Marko-Varga,et al. Preferential expression of potential markers for cancer stem cells in large cell neuroendocrine carcinoma of the lung. An FFPE proteomic study , 2011, Journal of Clinical Bioinformatics.
[48] J. Farrés,et al. Biological Role of Aldo–Keto Reductases in Retinoic Acid Biosynthesis and Signaling , 2012, Front. Pharmacol..
[49] J. M. Petrash,et al. Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers , 2012, Front. Pharmacol..
[50] Bruce E Johnson,et al. The Introduction of Systematic Genomic Testing for Patients with Non–Small-Cell Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[51] L. Wong,et al. Proteomics Signature Profiling (PSP): A Novel Contextualization Approach for Cancer Proteomics , 2012, Journal of proteome research.
[52] Valerie L. Miller,et al. Aldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinoma. , 2012, International journal of clinical and experimental pathology.
[53] Ashish Saxena,et al. Aldose reductase inhibition prevents colon cancer growth by restoring phosphatase and tensin homolog through modulation of miR-21 and FOXO3a. , 2013, Antioxidants & redox signaling.